Bleomycin-induced pulmonary hypertension: an underrated phenomenon with important implications in the setting of high-risk clinical scenarios
Keywords:
Bleomycin, pulmonary hypertension, implications, major surgeryReferences
- Jayakrishnan B, Kausalya R, Al-Rashdi HA, et al. Bleomycin and perioperative care: a case report. Sarcoidosis Vasc Diffuse Lung Dis. 2023 Sep 13; 40(3):e2023030. doi: 10.36141/svdld.v40i3.14385.
- Demirkol B, Gul S, Cörtük M, et al. Protective efficacy of pirfenidone in rats with pulmonary fibrosis induced by bleomycin. Sarcoidosis Vasc Diffuse Lung Dis. 2023 Sep 13 ;40(3):e2023036. doi: 10.36141/svdld.v40i3.13847.
- Gürdoğan M, Demir M, Yalta K, Gülertop Y. Cancer Therapy-Related Pulmonary Hypertension: A Review of Mechanisms and Implications for Clinical Practice. Anatol J Cardiol. 2023; 27(6): 299-307. doi: 10.14744/AnatolJCardiol.2023.3013.
- Humbert M, Kovacs G, Hoeper MM, et al; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022; 43(38): 3618-3731. doi: 10.1093/eurheartj/ehac237.
- Ruffenach G, Hong J, Vaillancourt M, et al. Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights. Respir Res. 2020; 21(1): 303. doi: 10.1186/s12931-020-01570-2.
- Singh N, Dorfmüller P, Shlobin OA, Ventetuolo CE. Group 3 Pulmonary Hypertension: From Bench to Bedside. Circ Res. 2022; 130(9): 1404-1422. doi: 10.1161/CIRCRESAHA.121.319970.
- Yalta K, Yalta T, Gurdogan M, et al. Cardiac Biomarkers in the Setting of Asthma Exacerbations: a Review of Clinical Implications and Practical Considerations. Curr Allergy Asthma Rep. 2020; 20(6): 17. doi: 10.1007/s11882-020-00909-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 KENAN YALTA, CAFER ZORKUN, ERTAN YETKIN
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
